Across TCGA pan-cancer cohorts, SNX18P26 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated SNX18P26 data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher SNX18P26 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNX18P26 expression acts as an unfavorable survival marker, although some lineages such as CESC and PAAD show a favorable association.
KIRP, CESC, and PAAD are the cancer types where SNX18P26 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.